DA
David Amsellem Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
43
Avg Return
Past Year
Past Year
9.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
83.3%
Neutral
16.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Reiterated
| $41 |
24%
upside
| 2 | +3.2% |
0
%
| 4 Mar ‘26 5 hours ago |
|
|
|
Overweight
Initiated
| $48 |
98%
upside
| 1 | +5.2% |
0
%
| 27 Feb ‘26 5 days ago |
|
|
|
Overweight
Maintained
| $75 |
22%
upside
| 2 | +7.9% |
0
%
| 23 Feb ‘26 9 days ago |
|
|
|
Overweight
Maintained
| $432 |
15%
upside
| 1 | +6.9% |
0
%
| 18 Feb ‘26 14 days ago |
|
|
|
Overweight
Maintained
| $299 |
28%
upside
| 1 | +5.7% |
0
%
| 18 Feb ‘26 14 days ago |
|
|
|
Neutral
Maintained
| $177 |
4%
downside
| 1 | – |
–
| 9 Feb ‘26 23 days ago |
|
|
|
Neutral
Maintained
| $12 |
20%
downside
| 1 | – |
–
| 28 Jan ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $223 |
36%
upside
| 1 | -5.8% |
0
%
| 16 Jan ‘26 1 month ago |
|
|
|
Overweight
Initiated
| $18 |
123%
upside
| 1 | +5.5% |
0
%
| 9 Jan ‘26 1 month ago |
|
|
|
Overweight
Reiterated
| $219 |
16%
upside
| 1 | +31% |
0
%
| 10 Dec ‘25 2 months ago |
|